Loading
If this is the first time anyone has visited this substance, we may be fetching live data from TGA Product Information, PBS, and state framework sources — that can take up to a minute. Cached substances load in a second or two.
Raltegravir, sold under the brand name Isentress, is an antiretroviral medication used, together with other medication, to treat HIV/AIDS. It may also be used, as part of post-exposure prophylaxis, to prevent HIV infection following potential exposure. It is taken by mouth.
Read the full article on WikipediaHIV infection Clinical criteria: Treatment Phase: Initial Patient must be antiretroviral treatment naive, AND The treatment must be in combination with other antiretroviral agents.
“As an integrase inhibitor, raltegravir targets integrase, an enzyme common to retroviruses that integrates the viral genetic material into human chromosomes, a critical step in the HIV infection model.[medical citation needed] The drug is metabolized away via glucuronidation.”
“9 hours”
Working under the parallel aged-care framework? Aged-care equivalent →